MiraLax (polyethylene glycol 3350) is one of the most studied and widely recommended over-the-counter laxatives, with clinical trials showing it works for roughly 80 to 90 percent of people who use it consistently. But that still leaves a meaningful group who take it as directed and remain uncomfortable, bloated, or unable to have a satisfying bowel movement. If you’re in that group, the situation is frustrating but far from hopeless. There’s a structured set of next steps, ranging from simple fixes you can try today to prescription medications and specialized therapies that target the specific reason your constipation is resisting treatment.
Make Sure the Basics Are Right First
Before concluding that MiraLax has failed, it’s worth confirming you’re using it correctly. The standard recommended dose is 17 grams once daily, dissolved in about 8 ounces of liquid.1PubMed. OTC polyethylene glycol 3350 and pharmacists’ role in managing constipation That’s a level capful, not a heaping one. Mixing it in too little liquid or taking it sporadically rather than daily undermines its osmotic mechanism, which depends on enough water being drawn into the colon to soften stool consistently. Some people try MiraLax for three or four days, see no dramatic change, and give up. Clinical trials typically assess results over two to four weeks of daily use, so a brief trial may not be enough time.
Timing matters too. Taking MiraLax at the same time each day and pairing it with adequate overall hydration improves results. If you’ve been using it irregularly or at a low dose, a full two-week trial at the standard dose with consistent timing is worth completing before moving on. Your doctor may also temporarily suggest a higher dose for a short period, particularly if you have a significant stool burden that needs clearing before a maintenance approach can work.
Adding Fiber, but the Right Kind
If MiraLax alone isn’t doing enough, adding a soluble fiber supplement can help. Psyllium husk (the active ingredient in Metamucil) is the best-studied option. A randomized trial found that both psyllium and a mixed soluble/insoluble fiber supplement increased weekly complete spontaneous bowel movements from roughly 1.5 to about 3.5, with 75 percent of participants responding to either fiber type.2PubMed Central. Randomized clinical trial: soluble/insoluble fiber or psyllium for chronic constipation Fiber works through a different mechanism than MiraLax, adding bulk and stimulating motility, so the two can complement each other.
One important caveat: if your constipation involves significant bloating and your transit is already slow, dumping large amounts of insoluble fiber (wheat bran, raw vegetables) into your system can actually make things worse. Soluble fiber like psyllium absorbs water and forms a gel, which tends to be better tolerated. Start with a low dose and increase gradually over a week or two. If fiber supplementation produces only more gas and fullness without better bowel movements, that’s useful diagnostic information suggesting something beyond a simple fiber deficit is going on.
Check Whether Something Else Is Causing the Problem
No laxative works well when the underlying cause of constipation hasn’t been addressed. A surprisingly long list of common medications can slow your gut. Opioid painkillers are the most obvious culprit, but calcium channel blockers for blood pressure, iron supplements, certain antidepressants, antihistamines, and antacids containing aluminum all contribute. In older adults especially, multiple medications often stack up, and constipation results from the combined effect rather than any single drug.3PubMed Central. Chronic constipation in the elderly: a primer for the gastroenterologist
Medical conditions can also be the hidden driver. Hypothyroidism, diabetes, Parkinson’s disease, and neurological conditions all slow colonic transit. If you haven’t had basic blood work recently, it’s worth asking your doctor to check thyroid function and blood sugar. Constipation that doesn’t respond to standard treatment is sometimes the first noticeable symptom of one of these conditions, and treating the underlying problem often improves bowel function more than any laxative could on its own.
Pelvic Floor Dysfunction Is More Common Than You Think
This is the single most underdiagnosed reason MiraLax doesn’t work. Up to half of people with chronic constipation have a condition called dyssynergic defecation, where the muscles of the pelvic floor and anal sphincter fail to coordinate properly during a bowel movement.4PubMed Central. Diagnosis and Treatment of Dyssynergic Defecation Instead of relaxing when you bear down, the pelvic floor muscles tighten or contract, essentially creating a physical blockade. No amount of softening the stool with MiraLax solves this problem, because the issue isn’t stool consistency; it’s the exit mechanism.
People with dyssynergia often describe feeling like stool is right there but won’t come out, needing to strain excessively, or feeling like they haven’t fully emptied even after a bowel movement. These symptoms overlap with ordinary constipation, which is why the condition gets missed so often. Diagnosis typically involves anorectal manometry (a pressure-sensing test) and a balloon expulsion test, where you try to push out a small water-filled balloon. Research shows a strong correlation between what these tests reveal and what defecography imaging shows about actual rectal evacuation.5American Journal of Physiology-Gastrointestinal and Liver Physiology. Integrating anorectal manometry, balloon expulsion, and defecography: insights into diagnosing pelvic floor dysfunction If you’ve been struggling with constipation that doesn’t respond to laxatives, asking your gastroenterologist about anorectal function testing is one of the most productive steps you can take.
Biofeedback Therapy for Dyssynergia
If testing confirms pelvic floor dysfunction, the treatment of choice is biofeedback therapy, not more medication. Biofeedback uses visual or sensory feedback to teach you how to properly relax the pelvic floor muscles during defecation. It sounds almost too simple, but the evidence behind it is strong. In one large randomized controlled trial, 80 percent of biofeedback patients reported major improvement at six months, compared to just 22 percent treated with laxatives alone. Those benefits held up at one and two years of follow-up.6Gastroenterology. Biofeedback Is Superior to Laxatives for Normal Transit Constipation Due to Pelvic Floor Dyssynergia
Another randomized trial found that biofeedback corrected the abnormal muscle pattern in 12 of 13 patients, while standard treatment corrected it in none.7PubMed Central. Long Term Efficacy of Biofeedback Therapy for Dyssynergia – Randomized Controlled Trial Across multiple studies, biofeedback has proven more effective than laxatives, muscle relaxant drugs, and sham treatments for this specific type of constipation.8PubMed Central. Biofeedback therapy for dyssynergic defecation The catch is that biofeedback only works for dyssynergic defecation, not for slow-transit constipation, which is why getting the right diagnosis matters so much. Sessions typically involve a specialized physical therapist and are done over several weeks.
Prescription Medications When Over-the-Counter Options Fall Short
When MiraLax and fiber aren’t enough and pelvic floor dysfunction has been ruled out or treated, several prescription drugs target constipation through mechanisms entirely different from osmotic laxatives.
Secretagogues are a class of drugs that stimulate fluid secretion into the intestinal lining. Linaclotide (Linzess), lubiprostone (Amitiza), and plecanatide (Trulance) have all been shown to outperform placebo in clinical trials.9PubMed. Efficacy of Secretagogues in Patients With Irritable Bowel Syndrome With Constipation: Systematic Review and Network Meta-analysis Plecanatide, for instance, has been shown in a meta-analysis to nearly double the rate of complete spontaneous bowel movements within 24 hours compared to placebo in people with chronic constipation.10European Journal of Gastroenterology & Hepatology. Efficacy and tolerability of plecanatide for irritable bowel syndrome with constipation and chronic idiopathic constipation: a systematic review and meta-analysis These drugs are especially useful if your constipation includes abdominal pain or if you have a diagnosis of irritable bowel syndrome with constipation.
Prucalopride (Motegrity) works differently. It’s a prokinetic, meaning it stimulates the nerves that coordinate the wave-like contractions moving stool through the colon. In a placebo-controlled trial of people with severe chronic constipation, about 31 percent of those taking prucalopride achieved three or more complete spontaneous bowel movements per week, compared to 12 percent on placebo.11PubMed. A placebo-controlled trial of prucalopride for severe chronic constipation In a separate trial focused specifically on patients who had already failed laxative therapy, prucalopride still produced significant improvements in bowel frequency and quality of life.12PubMed. Prucalopride (Resolor) in the treatment of severe chronic constipation in patients dissatisfied with laxatives This makes it a particularly relevant option when MiraLax hasn’t worked, because it was tested in precisely that population.
A Simple Posture Change That Helps More Than Expected
This won’t replace medical treatment for severe constipation, but it’s free and backed by real data. Using a toilet stool (sometimes called a squatty potty or defecation posture modification device) to elevate your feet while sitting on the toilet shifts your body closer to a squatting position, straightening the anorectal angle and making evacuation easier. In a study of healthy adults, using one of these stools increased the odds of feeling complete emptiness by more than threefold and reduced straining in about 90 percent of participants.13PubMed Central. Implementation of a Defecation Posture Modification Device Impact on Bowel Movement Patterns in Healthy Subjects A broader review of toilet posture research concluded that squatting positions generally reduce digestive strain and enhance bowel evacuation compared to standard sitting.14PubMed Central. Sitting vs. squatting: a scoping review of toilet postures and associated health outcomes
The research extends to children too. A pilot study of children with functional constipation found no injuries or adverse events from using a toilet stool, and 98 percent of families said they would recommend it. Children using the stool had a meaningful reduction in fecal incontinence compared to non-users.15PubMed. Potty Stools, a Pilot Study to Step Up the Management of Functional Constipation in Children This is the kind of low-risk intervention worth trying alongside anything else you’re doing.
Getting the Right Diagnosis With Transit Testing
If you’ve tried multiple treatments without success, your gastroenterologist may recommend transit testing to determine whether your colon is physically moving stool too slowly. The traditional method involves swallowing a capsule containing small radiopaque markers, then getting an X-ray several days later to see how many have passed through. A newer option, the wireless motility capsule, measures pressure, pH, and temperature as it travels through your entire digestive tract, providing information about both colonic transit and whole-gut transit without radiation exposure.16PubMed. Investigation of colonic and whole-gut transit with wireless motility capsule and radiopaque markers in constipation
Studies comparing the two methods show about 87 percent agreement in distinguishing slow transit from normal transit.17PubMed Central. Wireless pH-motility capsule for colonic transit: prospective comparison with radiopaque markers in chronic constipation In older adults, the wireless capsule had slightly better diagnostic performance and offers the advantage of being radiation-free.18PubMed. Evaluation of constipation in older adults: radioopaque markers (ROMs) versus wireless motility capsule (WMC) Why does this matter practically? Because knowing whether your transit is genuinely slow versus normal changes the treatment plan. Slow-transit constipation responds to prokinetics and secretagogues. Normal-transit constipation with difficulty evacuating points toward pelvic floor dysfunction and biofeedback. Treating the wrong subtype explains a lot of treatment failures.
Transanal Irrigation When Other Options Stall
For constipation that persists despite medications and behavioral therapy, transanal irrigation is a step between conservative treatment and surgery. It involves instilling water into the rectum and lower colon using a specialized device, essentially a controlled, higher-volume version of an enema designed for regular use. A systematic review and meta-analysis found a pooled response rate of about 51 percent in adults with chronic functional constipation.19PubMed Central. Trans-anal irrigation therapy to treat adult chronic functional constipation: systematic review and meta-analysis That’s far from perfect, but for people who have exhausted other options, a coin-flip chance of meaningful improvement is worth trying before considering surgery. A more recent systematic review noted that high-volume irrigation may be more effective than low-volume approaches, though the evidence remains limited to mostly observational studies.20PubMed Central. Transanal irrigation: Bridging the gap in treatment for chronic constipation and/or faecal incontinence-A systematic review and management guidance
Gut-Directed Behavioral Therapies
Constipation, especially when it overlaps with irritable bowel syndrome, has a significant brain-gut component. Stress, anxiety, and hypervigilance about bowel habits can worsen symptoms through pathways connecting the central nervous system and the enteric nervous system. Cognitive behavioral therapy and gut-directed hypnotherapy have both shown the ability to improve digestive symptoms, psychological well-being, and quality of life in people with functional gastrointestinal disorders.21PubMed. Hypnosis and Cognitive Behavioral Therapies for the Management of Gastrointestinal Disorders Cognitive behavioral therapy in particular has level-one evidence supporting its use in functional GI conditions.22PubMed Central. Gut‐focused hypnotherapy for Functional Gastrointestinal Disorders: Evidence‐base, practical aspects, and the Manchester Protocol
These therapies aren’t about being told the problem is “in your head.” They address measurable physiological changes: altered gut motility driven by stress hormones, heightened visceral sensitivity, and maladaptive behaviors like excessive straining or toilet avoidance. If your constipation worsens with stress or you notice a strong connection between your emotional state and your gut, these approaches can add a layer of improvement that medications alone don’t reach.
When Refractory Constipation Gets a Formal Diagnosis
Gastroenterologists have a specific clinical definition for constipation that defies treatment. Refractory constipation is diagnosed when bowel habits remain infrequent or unsatisfactory despite adequate trials of lifestyle changes, dietary measures, medications, and biofeedback when indicated. The criteria include things like fewer than three complete bowel movements per week on current therapy, worsening straining, stool consistency that remains hard, or side effects bad enough that whatever relief you’re getting isn’t worth it.23Clinical Gastroenterology and Hepatology. AGA Clinical Practice Update on Evaluation and Management of Refractory Constipation: Expert Review Having this formal classification matters because it opens the door to more aggressive interventions and ensures your doctor has systematically ruled out the more treatable causes before escalating.
Sacral Neuromodulation and Surgical Options
For the small percentage of people whose constipation truly resists everything else, there are procedural options, though the evidence is more sobering than for the treatments discussed above. Sacral neuromodulation involves implanting a device that delivers mild electrical stimulation to the nerves controlling the colon and pelvic floor. In one long-term study, 45 out of 62 patients who underwent test stimulation proceeded to permanent implantation, but only 18 patients (29 percent) made it to the five-year follow-up. Among the ten who completed bowel diaries at that point, improvement in bowel frequency was sustained, roughly doubling from about four to eight defecations per week. However, device-related adverse events were reported in 61 percent of those who received implants.24SpringerOpen. Long-term outcome of sacral neuromodulation for chronic refractory constipation The high dropout rate and frequent device complications make this a genuinely last-resort option.
Subtotal colectomy, the surgical removal of most of the colon, is reserved for severe slow-transit constipation confirmed by testing, where the colon simply doesn’t contract effectively. It can produce dramatic improvements in bowel frequency, but it carries real surgical risks and can result in diarrhea, urgency, or other long-term issues. Careful patient selection and thorough pre-surgical workup (ruling out pelvic floor dysfunction, which surgery won’t fix) are critical.
Fecal Microbiota Transplant as an Emerging Approach
Fecal microbiota transplantation, more commonly associated with treating recurrent C. difficile infections, is being investigated for chronic constipation as well. A recent systematic review and meta-analysis reported a pooled remission rate of about 51 percent and an improvement rate of roughly 65 percent, along with meaningful gains in stool consistency and quality of life. Post-transplant analyses showed increases in beneficial gut bacteria and decreases in pro-inflammatory species.25Frontiers in Microbiology. Fecal microbiota transplantation for chronic constipation: a systematic review and meta-analysis of clinical efficacy, safety, and microbial dynamics These results are promising but preliminary. Most of the included studies were small, and this is not yet a standard clinical treatment for constipation. It’s worth knowing about if you’re someone who has exhausted conventional options and is looking for what’s on the horizon, but it’s not something most gastroenterologists would offer outside of a research setting today.
The broader point about the microbiome is that chronic constipation is associated with shifts in gut bacterial populations, and whether these shifts are a cause or a consequence of slow transit is still being sorted out. Probiotic supplements are widely marketed for constipation, but the evidence for specific strains and doses remains inconsistent. If you want to try probiotics, look for strains with at least some trial data behind them (Bifidobacterium lactis is among the better-studied options) and give them a fair trial of several weeks, but keep your expectations moderate.